Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$68,367
+$25,138 QoQ
Shares Held
57
+21.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4,510
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCGUIRE CAPITAL ADVISORS INC holds $1,851,944 across 12 Drug Manufacturers - General names. LLY ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,431 | $863,376 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
5,889 | $339,324 | |
| 3 | JNJ |
Johnson & Johnson
|
1,230 | $312,383 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,025 | $131,712 | |
| 5 | PFE |
Pfizer Inc
|
3,528 | $84,954 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
57 | $68,367 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
202 | $25,520 | |
| 8 | AMGN |
Amgen Inc
|
69 | $24,986 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,367 | 57 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $43,229 | 47 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $37,613 | 35 | Shares | Sole | 2026-02-19 | |
| No filing history on record for this holder in this stock. | ||||||